Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)
Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68788-7997
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68788-7997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)
Results for subgroups in MERITHE trial including data on relative risk and 95% confidence interval for different subgroups. The trial included both Metoprolol and Placebo groups. There is also data available on time to first event (TTFE) and heart rate status (HRSTS), among other variables like New York Heart Association (NYHA) classification, ejection fraction (EF), and myocardial infarction (MI).*
Metoprolol Succinate Extended-release Tab Usp 50mg (Fe222a69 B261 4e41 83ab Af76ee17812d 04)
The text contains information about Metoprolol Succinate Extended-Release tablets, which come in two dosages: 50mg and 80mg. It warns that transferring this medication to others is illegal without a valid prescription. The tablets are indicated to treat high blood pressure, chest pain, and heart failure. It also includes details of the manufacturer and batch numbers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
